Management of fetal tumors

Publication date: Available online 14 January 2019Source: Best Practice & Research Clinical Obstetrics & GynaecologyAuthor(s): Sophie Masmejan, David Baud, Greg Ryan, Tim Van MieghemAbstractIn this review article, we discuss the most common fetal tumors, their prenatal management and outcomes. Overall, the most important outcome predictors are tumor histology, size, vascularity and location. Very large lesions, lesions causing cardiac failure and hydrops and lesions obstructing the fetal airway have the poorest outcome as they may cause fetal death or complications at the time of delivery. Fetal therapy has been developed to improve outcomes for these most severe cases and can consist of transplacental therapy (sirolimus for rhabdomyomas or steroids for hemangiomas and microcystic lung lesions) or surgical intervention (shunting of cystic masses, tumor ablation, occlusion of blood flow or airway exploration and protection). Given the rarity of fetal tumors, patients should be referred to expert centers where care can be optimized and individualized to allow the best possible outcomes.
Source: Best Practice and Research Clinical Obstetrics and Gynaecology - Category: OBGYN Source Type: research
More News: Hemangioma | OBGYN